1. Home
  2. GKOS vs CRK Comparison

GKOS vs CRK Comparison

Compare GKOS & CRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GKOS
  • CRK
  • Stock Information
  • Founded
  • GKOS 1998
  • CRK 1983
  • Country
  • GKOS United States
  • CRK United States
  • Employees
  • GKOS N/A
  • CRK N/A
  • Industry
  • GKOS Medical/Dental Instruments
  • CRK Oil & Gas Production
  • Sector
  • GKOS Health Care
  • CRK Energy
  • Exchange
  • GKOS Nasdaq
  • CRK Nasdaq
  • Market Cap
  • GKOS 5.1B
  • CRK 5.8B
  • IPO Year
  • GKOS 2015
  • CRK N/A
  • Fundamental
  • Price
  • GKOS $94.31
  • CRK $23.29
  • Analyst Decision
  • GKOS Strong Buy
  • CRK Hold
  • Analyst Count
  • GKOS 13
  • CRK 11
  • Target Price
  • GKOS $135.15
  • CRK $17.72
  • AVG Volume (30 Days)
  • GKOS 914.5K
  • CRK 1.9M
  • Earning Date
  • GKOS 04-30-2025
  • CRK 07-29-2025
  • Dividend Yield
  • GKOS N/A
  • CRK N/A
  • EPS Growth
  • GKOS N/A
  • CRK N/A
  • EPS
  • GKOS N/A
  • CRK N/A
  • Revenue
  • GKOS $404,523,000.00
  • CRK $1,431,537,000.00
  • Revenue This Year
  • GKOS $27.89
  • CRK $39.74
  • Revenue Next Year
  • GKOS $27.57
  • CRK $22.88
  • P/E Ratio
  • GKOS N/A
  • CRK N/A
  • Revenue Growth
  • GKOS 23.92
  • CRK 1.43
  • 52 Week Low
  • GKOS $77.10
  • CRK $7.74
  • 52 Week High
  • GKOS $163.71
  • CRK $24.70
  • Technical
  • Relative Strength Index (RSI)
  • GKOS 50.08
  • CRK 57.66
  • Support Level
  • GKOS $93.52
  • CRK $22.84
  • Resistance Level
  • GKOS $101.57
  • CRK $24.70
  • Average True Range (ATR)
  • GKOS 3.33
  • CRK 0.75
  • MACD
  • GKOS 0.40
  • CRK -0.13
  • Stochastic Oscillator
  • GKOS 42.24
  • CRK 40.25

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

About CRK Comstock Resources Inc.

Comstock Resources Inc is an independent natural gas producer operating in the Haynesville shale, a natural gas basin located in North Louisiana and East Texas with superior economics given its geographical proximity to the Gulf Coast natural gas markets. The Company operates in one business segment, the exploration and production of North American natural gas and oil. It is engaged in the acquisition, development, production, and exploration of oil and natural gas. Its oil and gas operations are concentrated in Louisiana and Texas.

Share on Social Networks: